Patients with breast cancer who take opioids to manage their pain are less likely to adhere to adjuvant therapy, resulting in a higher risk of death. READ MORE

Conferences

Genomic analysis revealed differences in the landscape of estrogen receptor-positive cancers when compared with ER+ primary tumors.

READ MORE

Observation for adverse reactions following trastuzumab serves as an unnecessary use of health resources.

READ MORE

Common menopausal symptoms can be used as predictive tools for adherence to the aromatase inhibitor tamoxifen.

READ MORE

Researchers conducted a study to generate estimates of costs associated with breast cancer adjuvant chemotherapy regimens.

READ MORE

News

Patients with breast cancer who take opioids to manage their pain are less likely to adhere to adjuvant therapy, resulting in a higher risk of death.

READ MORE

By Megan Brooks

NEW YORK (Reuters Health) - Omitting radiation after lumpectomy for pure ductal carcinoma in situ (DCIS) does not improve the chance of breast preservation in case of local recurrence, researchers from Canada have observed.

READ MORE

A recent comparative effectiveness study examined long-term survival outcomes for patients with breast cancer after undergoing either mastectomy or breast-conserving surgery.

READ MORE

Research in Review

An immuno-agent improves PFS and lowers the risk of death for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation.

READ MORE

A low level of stromal cytotoxic T-cell infiltration in breast cancer tumor specimens predicts patients who may benefit most from antibody- vs molecular-based HER2 inhibitors.

READ MORE

Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy.

READ MORE

A neoadjuvant chemotherapy combination used to treat breast cancer increases the risk of disease metastasis.

READ MORE

Resources

The American College of Obstetricians and Gynecologists has recently updated its clinical guidelines for the management of hereditary breast and ovarian cancer syndrome.

READ MORE